信息搜索
信息关键字：药
  

共有5342条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268]

·西南证券：医药带量采购为创新药带来发展机会2018-9-21 10:57:28
·国家试点带量采购或重塑医药行业格局多家药企回应政策影响2018-9-21 8:48:36
·中药企业加速布局转型生物创新药成投资重点(附股)2018-9-21 8:44:25
·复星医药：带量采购政策有利于将质高价优的产品引入市场2018-9-21 8:32:08
·国家试点带量采购或重塑医药行业格局多家药企回应政策影响2018-9-21 8:28:16
·中药企业加速布局转型生物创新药成投资重点(附股)2018-9-21 8:24:26
·84家药企发布三季报业绩预告24家预计净利润涨幅超50%2018-9-21 8:19:35
·84家药企发布三季报业绩预告24家预计净利润涨幅超50%2018-9-21 7:42:04
·84家药企发布三季报业绩预告24家预计净利润涨幅超50%2018-9-21 7:41:49
·南京医药：第八届董事会第三次会议决议公告2018-9-21 1:51:02
·白药控股拟被吸收合并整体上市云南白药市值缩水2018-9-21 1:22:02
·南京医药：拟3.35亿收购南京华东医药股权与金陵大药房股权2018-9-20 18:37:29
·上海凯宝：受让“熊胆滴丸”药品生产技术获药监局同意2018-9-20 17:46:27
·创新层维和药业2017年虚增库存1.87亿被云南证监局要求改正2018-9-20 12:17:05
·药明康德启动在港上市程序或成第三只A+H医药股2018-9-20 3:21:35
·国药股份：第七届董事会第八次会议决议公告2018-9-19 23:34:25
·因2017年年报信息披露存在问题维和药业收到云南证监局责令改正措施决定书2018-9-19 22:51:08
·成功登陆A股后“不差钱”的药明康德又奔赴港股！2018-9-19 22:27:59
·众生药业：控股股东减持公司1.04%股份2018-9-19 17:51:00
·国办：推进公立医疗机构集中带量采购推动降药价2018-9-19 17:42:32

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268]